ArticleCancer medicine2025

De Novo EGFR -ALK and EGFR -ROS1 Co-Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis.

Lili Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.